Clinical Trial

Hemodynamic Measurements of Macrocirculatory and Perfusion Parameters in ICU

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
In septic shock there is growing evidence of a state of hemodynamic "disconnection" with seemingly adequate macrocirculatory values despite actual microcirculation failing to meet cellular demand. Norepinephrine (NE) is recommended as first choice vasoactive agent for the treatment of septic shock. However, the dynamic effects of NE on macro- and microcirculation and perfusion parameters has not been described in detail in the context of septic shock, precluding rational individualized titration of NE and fluids, as recommended recently. In the present prospective observational multicenter study in adult septic shock patients, we intend to explore the effects of NE on preload dependency and tissue perfusion by evaluating the correlation and potential discrepancies between macro- and microcirculation both during titration of NE and after fluid resuscitation. The conclusions drawn from our study will contribute to the physiological knowledge necessary for establishing individualized evidence-based bedside management of hemodynamics in the setting of septic shock.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-01-26; most recent amendment 2025-03-05.
Status change: Not Yet Recruiting → Recruiting 2022-03-09
Trial Details
NCT Number NCT05225402
Lead Sponsor Copenhagen University Hospital, Hvidovre
Collaborators: University Hospital Bispebjerg and Frederiksberg
Conditions Septic Shock, Hemodynamic Instability, Vasoconstriction
Enrollment 45 participants
Start Date 2022-03-08
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-07